Cargando…

Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance

Amotosalen and ultraviolet A (UVA) photochemical-based pathogen reduction using the Intercept™ Blood System (IBS) is an effective and established technology for platelet and plasma components, which is adopted in more than 40 countries worldwide. Several reports point towards a reduced platelet func...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stivala, Simona, Gobbato, Sara, Infanti, Laura, Reiner, Martin F., Bonetti, Nicole, Meyer, Sara C., Camici, Giovanni G., Lüscher, Thomas F., Buser, Andreas, Beer, Jürg H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622849/ https://www.ncbi.nlm.nih.gov/pubmed/28729303 http://dx.doi.org/10.3324/haematol.2017.164137

Ejemplares similares

Pathogen inactivation treatment of triple‐dose apheresis platelets with amotosalen and ultraviolet a light
por: Infanti, Laura, et al.
Publicado: (2022)

Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
por: Infanti, Laura, et al.
Publicado: (2019)

Glycoprotein Ib clustering in platelets can be inhibited by α-linolenic acid as revealed by cryo-electron tomography
por: Stivala, Simona, et al.
Publicado: (2020)

Assessment of dengue virus inactivation in random donor platelets using amotosalen and ultraviolet A illumination
por: Kumar, Ankit, et al.
Publicado: (2022)

Protein Concentrations in Stored Pooled Platelet Concentrates Treated with Pathogen Inactivation by Amotosalen Plus Ultraviolet a Illumination
por: Arnason, Niels Arni, et al.
Publicado: (2022)

Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
por: Lanteri, Marion C., et al.
Publicado: (2020)

Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
por: Girard, Yvette A., et al.
Publicado: (2020)

Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis
por: Bonetti, N. R., et al.
Publicado: (2019)

Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light
por: Hindawi, S.I., et al.
Publicado: (2022)

Whole blood omega-3 fatty acid concentrations are inversely associated with blood pressure in young, healthy adults
por: Filipovic, Mark G., et al.
Publicado: (2018)

Lifelong dietary omega-3 fatty acid suppresses thrombotic potential through gut microbiota alteration in aged mice
por: Saeedi Saravi, Seyed Soheil, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 in All Blood Components Using Amotosalen/Ultraviolet A Light and Amustaline/Glutathione Pathogen Reduction Technologies
por: Santa Maria, Felicia, et al.
Publicado: (2022)

Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma
por: Azhar, Esam I., et al.
Publicado: (2020)

Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study
por: Christensen, Christian, et al.
Publicado: (2020)

Evaluation of amotosalen and UVA pathogen‐reduced apheresis platelets after 7‐day storage
por: Cancelas, Jose A., et al.
Publicado: (2022)

Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units
por: Bubinski, Michal, et al.
Publicado: (2021)

InACTIVatINg cancer cachexia
por: Mathew, Sam J.
Publicado: (2011)

The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
por: Nebie, Ouada, et al.
Publicado: (2019)

A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment
por: Knutson, F, et al.
Publicado: (2015)

Ultraviolet-Based Pathogen Inactivation Systems: Untangling the Molecular Targets Activated in Platelets
por: Schubert, Peter, et al.
Publicado: (2018)

The Effects of Ultraviolet Light and Riboflavin on Inactivation of Viruses and the Quality of Platelet Concentrates at Laboratory Scale
por: Mirshafiee, Hamideh, et al.
Publicado: (2015)

Elevated levels of activated and inactivated thrombin-activatable fibrinolysis inhibitor in patients with sepsis
por: Park, Rojin, et al.
Publicado: (2010)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
por: Baumgartner, Philipp, et al.
Publicado: (2023)

Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality Parameters
por: Kovacic Krizanic, Katarina, et al.
Publicado: (2022)

RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity
por: Green, Alex B., et al.
Publicado: (2023)

Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor
por: Liberale, Luca, et al.
Publicado: (2019)

The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation
por: Reiner, Martin F., et al.
Publicado: (2021)

Aluminum plasmonic nanoshielding in ultraviolet inactivation of bacteria
por: Kunz, Jeremy N., et al.
Publicado: (2017)

Recent Advances in Molecular Diagnostics and Targeted Therapy of Myeloproliferative Neoplasms
por: Stivala, Simona, et al.
Publicado: (2021)

Effect of Short PEG on Near-Infrared BODIPY-Based Activatable Optical Probes
por: Inagaki, Fuyuki F., et al.
Publicado: (2020)

Predicting Inactivation of Bacillus subtilis Spores Exposed to Broadband and Solar Ultraviolet Light
por: Handler, F.A.
Publicado: (2019)

Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs)
por: Rae, Chris, et al.
Publicado: (2008)

THE ULTRAVIOLET LIGHT AND PHOTOSENSITIZED INACTIVATION OF TOBACCO MOSAIC VIRUS
por: Oster, Gerald, et al.
Publicado: (1950)

Dual Role of Endothelial Nitric Oxide Synthase in Oxidized LDL-Induced, p66(Shc)-Mediated Oxidative Stress in Cultured Human Endothelial Cells
por: Shi, Yi, et al.
Publicado: (2014)

Molecular Imaging with Activatable Reporter Systems
por: Niu, Gang, et al.
Publicado: (2012)

Broad-Band Activatable White-Opsin
por: Batabyal, Subrata, et al.
Publicado: (2015)

Tunable Protease-Activatable Virus Nanonodes
por: Judd, Justin, et al.
Publicado: (2014)

Conditionally Activatable Visible-Light Photocages
por: Bojtár, Márton, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_msrnm3kd0ntach71afnrbqefpl